$CHD
CHURCH & DWIGHT CO INC /DE/

2023 Q3 Form 10-Q Financial Statement

#000095017023035361 Filed on July 28, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $1.456B $1.454B
YoY Change 10.52% 9.74%
Cost Of Revenue $809.6M $815.3M
YoY Change 5.47% 4.55%
Gross Profit $646.3M $638.9M
YoY Change 17.57% 17.16%
Gross Profit Margin 44.39% 43.93%
Selling, General & Admin $222.7M $315.1M
YoY Change 43.58% 74.28%
% of Gross Profit 34.46% 49.32%
Research & Development $30.30M $30.20M
YoY Change 3.77% 11.03%
% of Gross Profit 4.69% 4.73%
Depreciation & Amortization $18.20M $55.80M
YoY Change 8.98% 232.14%
% of Gross Profit 2.82% 8.73%
Operating Expenses $253.0M $345.3M
YoY Change 37.28% 66.01%
Operating Profit $255.8M $293.6M
YoY Change 0.75% 12.23%
Interest Expense $27.20M -$25.90M
YoY Change 14.77% -234.2%
% of Operating Profit 10.63% -8.82%
Other Income/Expense, Net $3.700M $1.700M
YoY Change -511.11%
Pretax Income $234.0M $269.4M
YoY Change -0.21% 9.29%
Income Tax $56.50M $48.20M
% Of Pretax Income 24.15% 17.89%
Net Earnings $177.5M $221.2M
YoY Change -5.13% 18.23%
Net Earnings / Revenue 12.19% 15.21%
Basic Earnings Per Share $0.72 $0.90
Diluted Earnings Per Share $0.71 $0.89
COMMON SHARES
Basic Shares Outstanding 246.0M 244.3M
Diluted Shares Outstanding 248.7M 247.9M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $573.3M $396.9M
YoY Change 31.01% -37.96%
Cash & Equivalents $573.3M $396.9M
Short-Term Investments
Other Short-Term Assets $38.70M $43.20M
YoY Change -35.71% 2.37%
Inventory $671.7M $675.4M
Prepaid Expenses
Receivables $460.9M $460.9M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.745B $1.576B
YoY Change 11.52% -9.96%
LONG-TERM ASSETS
Property, Plant & Equipment $862.4M $958.7M
YoY Change 20.4% 45.13%
Goodwill $2.432B $2.430B
YoY Change 7.08% 7.03%
Intangibles $3.338B $3.370B
YoY Change -1.94% -1.89%
Long-Term Investments $13.60M $14.70M
YoY Change 14.29% 20.49%
Other Assets $311.9M $161.1M
YoY Change -2.65% -49.02%
Total Long-Term Assets $6.958B $6.935B
YoY Change 3.48% 3.59%
TOTAL ASSETS
Total Short-Term Assets $1.745B $1.576B
Total Long-Term Assets $6.958B $6.935B
Total Assets $8.702B $8.511B
YoY Change 5.0% 0.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $691.8M $677.7M
YoY Change 5.52% 1.57%
Accrued Expenses $485.9M $432.4M
YoY Change 29.09% 23.83%
Deferred Revenue
YoY Change
Short-Term Debt $3.800M $4.000M
YoY Change 15.15% 21.21%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.188B $1.122B
YoY Change -18.08% -35.04%
LONG-TERM LIABILITIES
Long-Term Debt $2.402B $2.401B
YoY Change 14.12% 14.12%
Other Long-Term Liabilities $270.2M $323.3M
YoY Change -0.7% 15.96%
Total Long-Term Liabilities $2.672B $2.724B
YoY Change 12.42% 14.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.188B $1.122B
Total Long-Term Liabilities $2.672B $2.724B
Total Liabilities $4.652B $4.600B
YoY Change 1.12% -5.94%
SHAREHOLDERS EQUITY
Retained Earnings $5.926B $5.815B
YoY Change 3.0% 3.29%
Common Stock $735.1M $716.3M
YoY Change 13.32% 11.42%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.581B $2.593B
YoY Change -3.26% -2.95%
Treasury Stock Shares
Shareholders Equity $4.051B $3.911B
YoY Change
Total Liabilities & Shareholders Equity $8.702B $8.511B
YoY Change 5.0% 0.78%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $177.5M $221.2M
YoY Change -5.13% 18.23%
Depreciation, Depletion And Amortization $18.20M $55.80M
YoY Change 8.98% 232.14%
Cash From Operating Activities $285.9M $236.1M
YoY Change 27.81% 49.81%
INVESTING ACTIVITIES
Capital Expenditures $58.30M $38.20M
YoY Change -198.31% -264.66%
Acquisitions
YoY Change
Other Investing Activities -$900.0K -$1.400M
YoY Change -43.75% 55.56%
Cash From Investing Activities -$59.20M -$39.60M
YoY Change -2.79% 64.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -47.60M -3.700M
YoY Change -86.71% -101.11%
NET CHANGE
Cash From Operating Activities 285.9M 236.1M
Cash From Investing Activities -59.20M -39.60M
Cash From Financing Activities -47.60M -3.700M
Net Change In Cash 179.1M 192.8M
YoY Change -191.66% -58.83%
FREE CASH FLOW
Cash From Operating Activities $285.9M $236.1M
Capital Expenditures $58.30M $38.20M
Free Cash Flow $227.6M $197.9M
YoY Change -19.58% 9.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0000313927
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccountsPayableAndOtherAccruedLiabilitiesCurrent
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccountsPayableAndOtherAccruedLiabilitiesCurrent
CY2023Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2022Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-10585
dei Entity Registrant Name
EntityRegistrantName
CHURCH & DWIGHT CO., INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-4996950
dei Entity Address Address Line1
EntityAddressAddressLine1
500 Charles Ewing Boulevard
dei Entity Address City Or Town
EntityAddressCityOrTown
Ewing
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
08628
dei City Area Code
CityAreaCode
609
dei Local Phone Number
LocalPhoneNumber
806-1200
dei Security12b Title
Security12bTitle
Common Stock, $1 par value
dei Trading Symbol
TradingSymbol
CHD
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
246046990
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1454200000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1325100000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2884000000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2622300000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
815300000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
779800000
us-gaap Cost Of Revenue
CostOfRevenue
1623100000
us-gaap Cost Of Revenue
CostOfRevenue
1524500000
CY2023Q2 us-gaap Gross Profit
GrossProfit
638900000
CY2022Q2 us-gaap Gross Profit
GrossProfit
545300000
us-gaap Gross Profit
GrossProfit
1260900000
us-gaap Gross Profit
GrossProfit
1097800000
CY2023Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
132200000
CY2022Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
102900000
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
254500000
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
204800000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
213100000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
180800000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
420900000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
350700000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
293600000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
261600000
us-gaap Operating Income Loss
OperatingIncomeLoss
585500000
us-gaap Operating Income Loss
OperatingIncomeLoss
542300000
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2000000
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3900000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6400000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6300000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1700000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
300000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
CY2023Q2 us-gaap Interest Expense
InterestExpense
27900000
CY2022Q2 us-gaap Interest Expense
InterestExpense
19300000
us-gaap Interest Expense
InterestExpense
56700000
us-gaap Interest Expense
InterestExpense
35900000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
269400000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
246500000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
538200000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
512700000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48200000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
59400000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
113800000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
121200000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
221200000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
187100000
us-gaap Net Income Loss
NetIncomeLoss
424400000
us-gaap Net Income Loss
NetIncomeLoss
391500000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
245000000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
242600000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
244400000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
242600000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
247900000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
246400000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
247400000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
246500000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.9
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.77
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.74
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.61
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.89
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.76
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.72
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.59
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.27
CY2022Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.26
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.54
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.53
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
221200000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
187100000
us-gaap Net Income Loss
NetIncomeLoss
424400000
us-gaap Net Income Loss
NetIncomeLoss
391500000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3300000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-12300000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5700000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-14500000
CY2022Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-0
CY2023Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-0
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1500000
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1900000
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-4900000
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
18400000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-5700000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
33700000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1600000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6100000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1500000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
21100000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
219600000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
193200000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
425900000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
412600000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
396900000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
270300000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3500000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3500000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
460900000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
422000000
CY2023Q2 us-gaap Inventory Net
InventoryNet
675400000
CY2022Q4 us-gaap Inventory Net
InventoryNet
646600000
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
43200000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
57000000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
1576400000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1395900000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
802400000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
761100000
CY2023Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
14700000
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
12700000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3369800000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3431600000
CY2023Q2 us-gaap Goodwill
Goodwill
2430300000
CY2022Q4 us-gaap Goodwill
Goodwill
2426800000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
317400000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
317500000
CY2023Q2 us-gaap Assets
Assets
8511000000
CY2022Q4 us-gaap Assets
Assets
8345600000
CY2023Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
4000000
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
74000000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
677700000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
666700000
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
432400000
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
436100000
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
7700000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
7000000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1121800000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1183800000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2400900000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2599500000
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
754000000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
757000000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
281300000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
273400000
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
42000000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
42000000
CY2023Q2 us-gaap Liabilities
Liabilities
4600000000
CY2022Q4 us-gaap Liabilities
Liabilities
4855700000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2500000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2500000
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
293709982
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
293709982
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
293700000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
293700000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
422600000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
366200000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5815300000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5524600000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-27800000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-29300000
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
47710884
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
49814106
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
2592800000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2665300000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
3911000000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3489900000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8511000000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8345600000
us-gaap Net Income Loss
NetIncomeLoss
424400000
us-gaap Net Income Loss
NetIncomeLoss
391500000
us-gaap Depreciation
Depreciation
34600000
us-gaap Depreciation
Depreciation
33400000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
76100000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
73900000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1900000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2400000
chd Income Loss From Equity Method Investments Excluding Impairment Charges
IncomeLossFromEquityMethodInvestmentsExcludingImpairmentCharges
6400000
chd Income Loss From Equity Method Investments Excluding Impairment Charges
IncomeLossFromEquityMethodInvestmentsExcludingImpairmentCharges
6300000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
4400000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
3200000
us-gaap Share Based Compensation
ShareBasedCompensation
39500000
us-gaap Share Based Compensation
ShareBasedCompensation
17900000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
200000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3300000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
32400000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7500000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
24300000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
133000000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-8800000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-10000000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-17100000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-62100000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
6600000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
2000000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
3300000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
11700000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
509200000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
310400000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
63200000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
38800000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
6000000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-69200000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39800000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
499800000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
200000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
-0
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-70600000
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-249500000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
88300000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
16900000
us-gaap Payments Of Dividends
PaymentsOfDividends
133000000
us-gaap Payments Of Dividends
PaymentsOfDividends
127400000
chd Payments Of Deferred Financing And Other Costs
PaymentsOfDeferredFinancingAndOtherCosts
100000
chd Payments Of Deferred Financing And Other Costs
PaymentsOfDeferredFinancingAndOtherCosts
7600000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-315400000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
132200000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2000000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3700000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
126600000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
399100000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
270300000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
240600000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
396900000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
639700000
us-gaap Interest Paid Net
InterestPaidNet
57900000
us-gaap Interest Paid Net
InterestPaidNet
32400000
us-gaap Income Taxes Paid
IncomeTaxesPaid
109200000
us-gaap Income Taxes Paid
IncomeTaxesPaid
117600000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
25400000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
17500000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3233200000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
204400000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
15000000
CY2022Q1 us-gaap Dividends Cash
DividendsCash
63700000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14000000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3402900000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
187100000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6100000
CY2022Q2 us-gaap Dividends Cash
DividendsCash
63700000
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
22000000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3554400000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3489900000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
203200000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3100000
CY2023Q1 us-gaap Dividends Cash
DividendsCash
66300000
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
37800000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3667700000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
221200000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1600000
CY2023Q2 us-gaap Dividends Cash
DividendsCash
66700000
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
90400000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
3911000000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
30200000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27200000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
56900000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
51700000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
873100000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
840100000
CY2023Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
150000000
CY2022Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
149500000
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
41800000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
46800000
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
483600000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
450300000
CY2023Q2 us-gaap Inventory Net
InventoryNet
675400000
CY2022Q4 us-gaap Inventory Net
InventoryNet
646600000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1675500000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1601200000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
802400000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
761100000
CY2023Q2 us-gaap Depreciation
Depreciation
17700000
CY2022Q2 us-gaap Depreciation
Depreciation
16800000
us-gaap Depreciation
Depreciation
34600000
us-gaap Depreciation
Depreciation
33400000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
245000000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
242600000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
244400000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
242600000
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2900000
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3800000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3000000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3900000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
247900000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
246400000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
247400000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
246500000
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2500000
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3000000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3900000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2900000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11900000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
62.64
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1000000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
83.55
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2100000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
42.91
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
200000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
81.1
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10600000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
68.16
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y2M12D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
343200000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6800000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
58.74
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y9M18D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
282300000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
97000000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
9500000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
107700000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
26300000
CY2023Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
4400000
CY2022Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
14700000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
18900000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
17500000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1.5
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1.5
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
21.43
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
24.03
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
21.45
CY2023Q2 us-gaap Stock Issued1
StockIssued1
0
CY2022Q2 us-gaap Stock Issued1
StockIssued1
31300000
us-gaap Stock Issued1
StockIssued1
24700000
us-gaap Stock Issued1
StockIssued1
31600000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.029
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.04
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.029
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y1M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y3M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y1M6D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.217
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.224
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.217
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.012
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.013
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.012
CY2021Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1000000000
CY2023Q2 chd Business Combination Cash Purchase Price Net Of Contingent Consideration
BusinessCombinationCashPurchasePriceNetOfContingentConsideration
546800000
chd Business Acquisition Additional Cash Payment
BusinessAcquisitionAdditionalCashPayment
8000000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
61500000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
179000000
us-gaap Business Combination Provisional Information Initial Accounting Incomplete Adjustment Consideration Transferred
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred
3500000
chd Cash Payments
CashPayments
3800000
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2238500000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
830500000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1408000000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2760900000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
879700000
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
411000000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1470200000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
31100000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
29300000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
62200000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
58800000
CY2023Q2 chd Finite Lived Intangible Assets Amortization Expense Current Year Estimate
FiniteLivedIntangibleAssetsAmortizationExpenseCurrentYearEstimate
124000000
us-gaap Impairment Charge On Reclassified Assets
ImpairmentChargeOnReclassifiedAssets
411000000
CY2023Q2 us-gaap Disposal Group Including Discontinued Operation Intangible Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent
46300000
CY2022Q4 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P3Y
chd Discount On Estimated Future Cashflow
DiscountOnEstimatedFutureCashflow
0.085
CY2023Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1961800000
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1961400000
CY2023Q2 chd Tradename Percentage Of Fair Value In Excess Of Carrying Amount
TradenamePercentageOfFairValueInExcessOfCarryingAmount
0.46
CY2023Q2 us-gaap Goodwill
Goodwill
2430300000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
156300000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
162600000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
23100000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
21900000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
145900000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
151900000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
169000000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
173800000
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y6M
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y10M24D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.045
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.044
CY2023Q2 us-gaap Lease Cost
LeaseCost
7900000
CY2022Q2 us-gaap Lease Cost
LeaseCost
7500000
us-gaap Lease Cost
LeaseCost
15600000
us-gaap Lease Cost
LeaseCost
15400000
CY2023Q2 chd Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net Of Modifications
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNetOfModifications
4100000
CY2022Q2 chd Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net Of Modifications
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNetOfModifications
15800000
chd Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net Of Modifications
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNetOfModifications
5100000
chd Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net Of Modifications
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNetOfModifications
17300000
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
7900000
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
8000000
us-gaap Operating Lease Payments
OperatingLeasePayments
15500000
us-gaap Operating Lease Payments
OperatingLeasePayments
15500000
chd Operating Lease Righ Of Use Asset Amortization
OperatingLeaseRighOfUseAssetAmortization
11900000
chd Operating Lease Righ Of Use Asset Amortization
OperatingLeaseRighOfUseAssetAmortization
12100000
CY2022Q2 chd Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
15200000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
15100000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
30000000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
28200000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
19900000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
18800000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
94900000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
206900000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
37900000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
169000000
CY2023Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
677700000
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
666700000
CY2023Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
225300000
CY2022Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
234400000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
78100000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
66800000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
129000000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
134900000
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1110100000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1102800000
CY2023Q2 chd Supply Chain Finance Program Outstanding Obligations
SupplyChainFinanceProgramOutstandingObligations
83200000
chd Supply Chain Financing Payments Included In Operating Activities Within The Companys Consolidated Statements Of Cash Flows
SupplyChainFinancingPaymentsIncludedInOperatingActivitiesWithinTheCompanysConsolidatedStatementsOfCashFlows
183900000
CY2023Q2 us-gaap Commercial Paper
CommercialPaper
0
CY2022Q4 us-gaap Commercial Paper
CommercialPaper
70600000
CY2023Q2 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
4000000
CY2022Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
3400000
CY2023Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
4000000
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
74000000
CY2023Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
19800000
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
21000000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2400900000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2599500000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-68200000
us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
34200000
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
300000
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
12800000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
21100000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-47100000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-29300000
us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
3800000
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
3700000
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-1400000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1500000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-27800000
CY2023Q2 us-gaap Foreign Currency Cash Flow Hedge Gain Loss Reclassified To Earnings Net
ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
2800000
CY2022Q2 us-gaap Foreign Currency Cash Flow Hedge Gain Loss Reclassified To Earnings Net
ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
100000
us-gaap Long Term Purchase Commitment Minimum Quantity Required
LongTermPurchaseCommitmentMinimumQuantityRequired
240000
us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
363400000
CY2023Q2 chd Outstanding Guarantees And Letters Of Credit
OutstandingGuaranteesAndLettersOfCredit
6400000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0000950170-23-035361-index-headers.html Edgar Link pending
0000950170-23-035361-index.html Edgar Link pending
0000950170-23-035361.txt Edgar Link pending
0000950170-23-035361-xbrl.zip Edgar Link pending
chd-20230630.htm Edgar Link pending
chd-20230630.xsd Edgar Link pending
chd-ex31_1.htm Edgar Link pending
chd-ex31_2.htm Edgar Link pending
chd-ex32_1.htm Edgar Link pending
chd-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img11584976_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
chd-20230630_def.xml Edgar Link unprocessable
chd-20230630_lab.xml Edgar Link unprocessable
chd-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
chd-20230630_htm.xml Edgar Link completed
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
chd-20230630_cal.xml Edgar Link unprocessable